Sunghoon Kim | |
---|---|
Born | 1958 (age 66–67) South Korea |
Alma mater | Ph.D. Brown University, U.S. |
Known for | Aminoacyl-tRNA Synthetases |
Awards | Korea Science Award, Ministry of Science and Technology (2003) Scientist of the Month, Korea Science and Engineering Foundation (KOSEF) (2003) Top Scientist and Technologist Award of Korea, Ministry of Science and Technology (2006) Award of Korean National Academy of Science (2012) |
Scientific career | |
Fields | Aminoacyl-tRNA synthetase, Translation, Cancer biology, Therapeutic target discovery |
Institutions | Seoul National University |
Doctoral advisor | Dr. Arthur Landy |
Korean name | |
Hangul | 김성훈 |
Revised Romanization | Gim Seonghun |
McCune–Reischauer | Kim Sŏnghun |
Dr. Kim Sunghoon is a South Korean biologist.
Dr. Sunghoon Kim has been studying novel functions of human aminoacyl-tRNA synthetases (ARSs) and searching for their pathophysiological connections to human diseases (PNAS 105:11043, [1] 2008; Nat Rev Cancer 11:708, 2011 [2] ). He has identified potent novel tumor suppressors such as AIMP2/p38 (Nat Genet 34:330, 2003 [3] ), AIMP3/p18 (Cell, 120:209, 2005 [4] ). Besides, he has also investigated novel extracellular activities of ARSs and associated factors such as lysyl-tRNA synthetase (KRS) (PNAS 102, 6356, 2005 [5] ), tryptophanyl-tRNA synthetase(WRS)(Nat Struct Mol Biol 11:149, 2004 [6] ) and AIMP1/p43 (PNAS 103:14913, 2006 [7] ). He also discovered the oncogenic variant of AIMP2, designated AIMP2-DX2, as one of the critical factors that determines the survival of lung cancer patients (Plos Genet 7:e1001351, 2011 [8] ). More recently[ when? ], he found that leucyl-tRNA synthetase (LRS) serves as an amino acid sensor for mTOR signal pathway (Cell 149:410, 2012 [9] ).